COMMENTARY: Low-carbon investment risks and de-risking

被引：170
|
作者：
Schmidt, Tobias S. [1 ,2 ]
机构：
[1] ETH, Swiss Fed Inst Technol Zurich, Dept Management Technol & Econ, Grp Sustainabil & Technol SusTec, CH-8092 Zurich, Switzerland
[2] Stanford Univ, Precourt Energy Efficiency Ctr, Stanford, CA 94305 USA
来源：
NATURE CLIMATE CHANGE | 2014年 / 4卷 / 04期
关键词：
D O I：
10.1038/nclimate2112
中图分类号：
X [环境科学、安全科学];
学科分类号：
08 ; 0830 ;
摘要：
Effective mitigation of climate change requires investment flows to be redirected from high- to low-carbon technologies. However, especially in developing countries, low-carbon investments often suffer from high risks. More research is needed to address these risks and allow sound policy decisions to be made.
引用
收藏
页码：237 / 239
页数：4
相关论文
共 50 条
  • [41] Pharmacokinetic de-risking tools for selection of monoclonal antibody lead candidates
    Dostalek, Miroslav
    Prueksaritanont, Thomayant
    Kelley, Robert F.
    MABS, 2017, 9 (05) : 756 - 766
  • [42] Low-Carbon Investment and Credit Rationing
    Haas, Christian
    Kempa, Karol
    ENVIRONMENTAL & RESOURCE ECONOMICS, 2023, 86 (1-2): : 109 - 145
  • [43] Economics: Support low-carbon investment
    Nathan Fabian
    Nature, 2015, 519 : 27 - 29
  • [44] Low-Carbon Investment and Credit Rationing
    Christian Haas
    Karol Kempa
    Environmental and Resource Economics, 2023, 86 : 109 - 145
  • [45] Climate risks of low-carbon power
    Nature, 2016, 530 (7591) : 385 - 385
  • [46] Low-carbon transition risks for finance
    Semieniuk, Gregor
    Campiglio, Emanuele
    Mercure, Jean-Francois
    Volz, Ulrich
    Edwards, Neil R.
    WILEY INTERDISCIPLINARY REVIEWS-CLIMATE CHANGE, 2021, 12 (01)
  • [47] Do green bonds de-risk investment in low-carbon stocks?
    Reboredo, Juan C.
    Ugolini, Andrea
    Ojea-Ferreiro, Javier
    ECONOMIC MODELLING, 2022, 108
  • [48] Text Mining for U.S. Pension De-Risking Analysis
    Zhang, Limin
    Tian, Ruilin
    Chen, Jun
    RISKS, 2022, 10 (02)
  • [49] De-risking the discovery and development of new drugs from bench to clinic
    Ilyin, SE
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (11) : 1031 - 1031
  • [50] De-risking Clinical Trials: The BIAL Phase I Trial in Foresight
    Cohen, Adam F.
    van Smeden, Jeroen
    Webb, David J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (02) : 362 - 365
12345